G
-protein-coupled receptors (GPRs) are increasingly being recognized with newer roles in blood pressure (BP) regulation because of their function as receptors for microbiotal metabolites, such as short chain fatty acids (SCFAs).
1,2 To date, there are 5 GPRs discovered as modulators of BP via binding to specific SCFAs. The G-protein-coupled estrogen receptor 1 (Gper1) is a relatively recently discovered GPRs, which belongs to the rhodopsin-like receptor super family. 3, 4 Originally categorized as an orphan receptor, 5 Gper1 is now recognized as a receptor for 2 ligands, estrogen [6] [7] [8] [9] and aldosterone. [10] [11] [12] Because of the feature of Gper1 being an estrogen receptor, the context for research on Gper1 was originally focused on cancer. Several studies have shown that disturbances in Gper1 expression are associated with development of breast, endometrial, and prostate cancers, [13] [14] [15] and roles of Gper1 in the nervous system are also emerging. 16 Identification of aldosterone as a second ligand prompted studies of Gper1 in BP regulation. Recent evidence suggests that some of the vasodilator effects of Gper1 are triggered through aldosterone-dependent stimulation of the receptor. [10] [11] [12] Pharmacological activation of Gper1 in rats has a lowering effect or no effect on BP 17, 18 ; however, Gper1 knockout mouse models have demonstrated both increasing and decreasing effects on BP. 9, 19 Given these conflicting reports, coupled with the discovery of several GPCRs as sensors of microbial metabolites, we hypothesized that the involvement of Gper1 in the regulation of cardiovascular disease may be contextually dependent on the microbiome of the animal model. To test this hypothesis, we examined the effect of deletion of Gper1 on the BP of the Dahl salt-sensitive rat model, whose genome is highly permissive for the development of hypertension, and whose microbiome has already been studied. 20 
Methods
All data and materials will be made publicly available at the Rat Genome Database.
Animals and Diet
All animal procedures and protocols used in this report were approved by the University of Toledo Institutional Animal Care and Use Committee and discussed in detail in the online-only Data Supplement. November 2018 extracted using TRIzol Reagent (Life Technologies), and cDNA was obtained by reverse transcription with SuperScript III (Invitrogen) using an OligodT primer. The cDNA samples were polymerase chain reaction (PCR) amplified using Gper1 exon-specific primers (sense 5′ CAGCAATATGTGATCGCTCTCT 3′ and antisense 5′ AAGCTGATGTTCACCACCAA 3′).
Genomic DNA Isolation, 16S rRNA Gene Sequencing, and Analysis of Microbiotal Composition
The fecal pellets of Gper1 +/+ (n=6-7) and Gper1 −/− (n=7-8) rats were collected at day 4 (before microbiota transplantation) and day 28 (after microbiota transplantation) and processed for analysis of microbial community (Wright Labs, LLC, PA), essentially as we described in ref. 20 and in detail in the online-only Data Supplement.
Targeted Metabolomics Profiling for SCFAs
Serum SCFAs were quantified at Penn State Metabolomics Core Facility, University Park, PA, as per previously published procedures 21, 22 and described in detail in the online-only Data Supplement.
BP Measurements by Radiotelemetry
All wild-type (Gper1
) hypertensive rats and Gper1 −/− rats were concomitantly bred, housed, and studied to minimize environmental effects. Surgical procedures were the same as previously described by us 23 and discussed in the online-only Data Supplement.
Evaluation of Vascular Reactivity by Wire Myography
Rats were euthanized (CO 2 inhalation), and the mesenteric artery was analyzed for vascular reactivity as described in detail in the onlineonly Data Supplement.
Microbiota Transplantation
Four-week old male and female Gper1 +/+ and Gper1 −/− rats were implanted with C-10 radiotransmitters (Data Sciences International, St. Paul, MN) to record BP. After recovery from surgery (3 days), a baseline systolic BP (SBP) reading was recorded for 1 hour (day 0). The resident microbiota was depleted using the protocol described previously by us 20 and described in the online-only Data Supplement.
Statistical Analysis
All statistical analyses of BP studies were conducted using GraphPad Prism 5 (version 5.02). Data were analyzed by independent sample Student t test or by repeated measures ANOVA as appropriate and specified in the results and figure legends. The data are presented as the mean±SEM. A P<0.05 was used as a threshold for statistical significance.
Results

CRISPR/Cas9-Based Genetic Ablation of Gper1
Rat Gper1 is a single exon gene with 1128 base pairs located on rat chromosome 12 (RNO12). To ensure complete gene deletion, 2 guide RNAs were designed on either end of the Gper1 gene. RNA validation performed via deletion PCR using a sense primer at the 5′ end and an antisense primer at the 3′ end showed a deletion PCR product of 544 bps versus wild-type PCR product of 1484 bps ( Figure S1 in the online-only Data Supplement). This confirmed the efficiency of the dual guide RNA approach to delete Gper1. Microinjection of 10 pseudopregnant rats resulted in a total of 5 homozygous founders, which were used for phenotypic studies. The homozygous founders had complete deletion of Gper1 ( Figure 1A ), which was confirmed by DNA sequencing ( Figure 1B ). Homozygous founders did not express mRNA for Gper1 as demonstrated by reverse transcription PCR ( Figure 1C ). rats was performed by sequencing for the 16S rRNA gene. 24 A total of 3 433 793 sequences were obtained after quality filtering and chimera picking (Table S1 ). α-Diversity analyses did not reveal differences between the 2 groups (data not shown). However, a β-diversity analysis revealed distinct community structures, showing significant phylogenetic differences between fecal samples (P=0.03; analysis of similarities [ANOSIM] test). A principal coordinates analysis plot reveals significant differences in microbial community structure between Gper1 −/− and Gper1 +/+ rats ( Figure 5B ). Figure S2 shows the relative abundance of bacterial communities in fecal samples from Gper1 (Tables S2 and S3 ).
Microbiotal Dysbiosis in
Attenuation of Hypertension in Gper1
−/− Rats After 24 days on a high-salt diet (2% NaCl), both Gper1
and Gper1 +/+ rats maintained normal diurnal rhythms of SBP and diastolic BP (DBP). However, throughout the observation period, both SBP and DBP, pulse pressure and mean arterial pressure in the Gper1 −/− rats were all consistently and markedly lower than that in the wild-type hypertensive rats, and this effect was observed in both females and males (Figure 2A and 2B; Figure S3 ). Moreover, by using repeated measures ANOVA, we were able to determine that there were significant differences within the strain in regards to time for SBP, DBP, pulse pressure, and mean arterial pressure. In addition, male and female Gper1 −/− rats had increased body weight and nasal-anal length compared with age-matched Gper1 +/+ rats (Table S4 ; Figure S4 ). The food and fluid intake were not measured in this study.
Improved Vascular Function in Gper1
−/− Rats Next, we examined the reactivity of secondary and tertiary order mesenteric arteries to the vasorelaxants acetylcholine and sodium nitroprusside. Whereas the response of Gper1
and Gper1 −/− arteries to phenylephrine was indistinguishable ( Figure 3A and 3D), the endothelium-dependent vasorelaxation response of mesenteric arteries from Gper1 −/− rats, as measured using a cumulative dose response to acetylcholine, was significantly higher than that of Gper1 +/+ rats ( Figure 3B  and 3E) . Importantly, the endothelium-independent relaxation induced by sodium nitroprusside was not affected by deletion of Gper1 ( Figure 3C and 3F).
Reversal of the BP-Lowering Effect After Return of the Gut Microbiota in Gper1
−/− Rats to That of Gper1 +/+ Rats
To evaluate whether the differences in BP between Gper1 +/+ and Gper1 −/− rats could be because of alterations in gut microbiota, we subjected male and female Gper1 −/− rats to a gut microbiota transplant protocol. 20, 25 Resident microbiota in Gper1 −/− animals were depleted by antibiotic treatment, and the cecal content of Gper1 +/+ rats was administered by oral gavage. As a control, Gper1 +/+ rats were subjected to microbiota depletion and received autologous cecal content from Gper1 +/+ animals. Notably, Gper1 −/− rats transplanted with cecal content from Gper1 +/+ rats no longer had the BP-lowering effect observed in Gper1 −/− rats ( Figure 4 ; Figure S5 ). By repeated measures ANOVA, there were significant increases in regards to time for each group for SBP, DBP, pulse pressure, and mean arterial pressure, as expected because these rats were on a high-salt diet during the −/− female and male rats was significantly lower than that of wild-type hypertensive rats (*P<0.05, **P<0.01, ***P<0.001).
course of weeks. To ensure successful transplantation, a microbiotal analysis of fecal samples of male Gper1 +/+ and Gper1 −/− rats before (day 4) and after (day 28) microbiota transplantation was performed by sequencing for the 16S rRNA gene. 24 α-and β-diversity analyses did not reveal differences between the 2 groups after transplantation (β-diversity seen in Figure 5A) . A principal coordinates analysis plot revealed significant differences in microbial community structure between Gper1 −/− and Gper1 +/+ rats before transplantation ( Figure 5B ), however, not at day 28 ( Figure 5C ), indicating that the microbiota of Gper1 −/− rats were successfully transplanted to be that of the donor Gper1 +/+ animals. The conversion of the Gper1 −/− gut microbiota signature to that of the donor Gper1 +/+ rats was also evident at the taxa level. After microbiota transplantation, the differences in microbial community between Gper1 −/− and Gper1 +/+ samples were minimal ( Figure 5E ). Of the most prevalent taxa, only Ruminococcus showed a 1.2% increase in abundance in Gper1 −/− compared with controls, whereas all remaining taxa yielded similar relative abundances between the 2 groups.
Plasma Circulating SCFAs in Gper −/− Rats
To assess whether there were differences in SCFAs as a result of the noted alterations in the microbiota, a targeted metabolomic study of serum samples from rats pre-and postcecal transfer was conducted. The results showed that only the circulating levels of acetate, but not propionate or butyrate (data not shown), were higher in the Gper1 −/− rats given cecal content from Gper1 +/+ rats ( Figure 6A ).
Vascular Response of Gper1 −/− Rats to SCFAs
To examine whether differences exist in the vascular response of Gper1 +/+ and Gper1 −/− rats to typical SCFAs, we evaluated the relaxation of phenylephrine-contracted mesenteric arteries when exposed to a submaximal dose (5 mmol/L) of acetate, propionate, or butyrate. As shown in Figure 6B , the 3 SCFAs caused an initial rapid, transient additional contraction and was followed by a sustained, slower relaxation phase that lasted for ≈10 minutes. The time-to-plateau of the acetate induced relaxation was significantly −/− rats. Principal coordinates analysis (PCoA) plots at day 4 and day 28 of male rats (A). PCoA plots were used to visualize differences in weighted Unifrac distances of fecal samples from the wild-type day 4 cohort (n=9), Gper1 −/− rat day 4 cohort (n=6), wild-type day 28 (n=6), and Gper1 −/− rat day 28 (n=7) samples. Points clustered more closely together are more similar in terms of phylogenetic distance, whereas points that are distant from each other are phylogenetically distinct. To further observe differences in β diversity between Gper1 −/− and wild-type rats within each time point, separate PCoA plots were generated for day 4 (B) and day 28 (C). Relative abundance plots to display differences in general microbial community structure between fecal samples collected from rats at day 4 (D) and day 28 (E). slower in Gper1 −/− compared with control vessels. In addition, the average of maximum relaxation induced by acetate was decreased in Gper1 −/− arteries (55%±5% versus 43%±4%; n=33-36 small mesenteric arteries/group; P=0.01). The time-to-plateau for butyrate induced relaxation was indistinguishable between Gper1 −/− and control vessels, but the average maximum relaxation was significantly decreased (61%±5% versus 47%±4%; n=34-36 small mesenteric arteries/group; P<0.001). Propionate induced relaxation was similar between the 2 groups (64%±4% versus 61%±4%; n=34-36 small mesenteric arteries/group; P=0.98).
Discussion
Over recent years, evidence has accumulated in support of a role of Gper1 in the regulation of vascular reactivity and BP. However, data on the role of Gper1 in cardiovascular disease are conflicting with pharmacological interventions and gene deletion models reporting both a protective and permissive nature of Gper1 on hypertension in particular. 9, 19 We present a novel CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 (CRISPR associated proteins)-edited deletion rat model of Gper1 using the Dahl salt-sensitive rat strain, a model of salt-sensitive hypertension, which provides a unique opportunity to examine the functionality of Gper1 in the context of hypertension. Three major findings ensued as a result. First, Gper1 −/− rats had significantly altered gut microbiota compared with the Gper1 +/+ rats. The microbiota alterations included a reduced Firmicutes:Bacteroidetes ratio, indicating that ablation of a single gene, Gper1, improved the dysbiosis evident in the Gper1 +/+ rats. Second, this reduced dysbiosis was associated with a significant reduction in both SBP and DBP compared with Gper1 +/+ rats in both males and females, which was accompanied by improvement in vascular function. Third, changing the composition of the gut microbiota of Gper1 −/− rats to that of Gper1 +/+ animals by cecal transplantation worsened BP in Gper1 −/− rats, indicating that the improved BP was because of the altered microbiota.
The prominent BP-lowering effect that resulted from genetic deletion of Gper1 in the Dahl salt-sensitive rat is not the same as previous studies in mouse and rat, in which activation of Gper1 promotes vasorelaxation and a lowering of BP. 9, 18, [26] [27] [28] However, the microbiota of these models were not characterized in these studies. The model that was used here, the Dahl salt-sensitive rat, not only has a highly permissive genomic background for the development of hypertension but also has a well-studied microbiome. 20 Besides providing a potential explanation to the apparently discrepant results, this also highlights the strong influence of the microbiome on functionality of a particular gene in BP regulation. Moreover, we recently showed that in this Dahl saltsensitive model, the composition of the gut microbiota strongly influences BP regulation. 20 With this precedent, we sought to determine whether the deletion of Gper1 rats was accompanied by differences in gut microbiota composition. This notion was reinforced by the unexpected results of the microbiota analysis of fecal samples from Gper1 −/− and Gper1 +/+ rats, which revealed marked differences in bacterial species richness between the 2 groups of animals, as shown by principal coordinates analysis plots and the taxonomic data. In particular, before the microbiotal transplant, Gper1 −/− rats exhibited significantly reduced levels of Clostridiales under the phylum Firmicutes in comparison to the wild-type Gper1 +/+ animals and had a marked decrease in the Firmicutes to Bacteroidetes ratio. This is interesting as a recent study showed an increased ratio of Firmicutes to Bacteroidetes in spontaneously hypertensive rats (hypertensive strain) as compared with Wistar Kyoto rats (normotensive strain). 29 Similar changes in gut microbiota composition were found in the chronic angiotensin II infusion rat model and in a small cohort of hypertensive patients. 29 Other studies confirmed that this ratio is significantly correlated with BP. [30] [31] [32] [33] Moreover, because of the similar genetic background between Gper1 −/− and wild-type Gper1 +/+ rats, the different composition of the gut microbiota between these strains suggests that Gper1 alters host symbiotic relationships with the gut microbial communities. One potential drawback of our study is that while the body weights and nasal-anal lengths of these rats were different, we did not measure the food, salt, or fluid intake, whereby it remains unknown whether these factors or the change in body weight contributed to the results. Therefore, it is possible that the altered body weight and food intake altered the microbiome independent of the genetic differences.
The ability of one gene to alter microbiota is not new but has been documented previously in mice with the Toll-like receptor 5 gene. 34 Toll-like receptor 5 knockout (Tlr5
) mice have significantly altered gut microbiota compared with control mice. 34 The altered microbiota had an increased Firmicutes to Bacteroidetes ratio, and the mice had associated metabolic disease and elevated BP. 34 To determine whether the changes in microbiota are causative for the BP-lowering effects observed, we transplanted cecal content from wild-type Gper1 +/+ rats. Our findings demonstrate that after colonization of the gut microbiota from wild-type Gper1 +/+ rats, the BP-lowering effect of Gper1 −/− was abolished in both sexes, and the BP was even slightly increased in female rats. This suggests that gut microbiota play a significant role in Gper1-dependent regulation of BP in hypertensive rats. Another experimental design to test the BP effect of microbiota from Gper1 −/− rats would be to transplant both Gper1 +/+ rats and Gper1 −/− rats with microbiota from Gper1 −/− rats, which has admittedly not been conducted in our study. This raises the question of whether a transplant from Gper1 −/− rats to Gper1 −/− rats may cause strain-specific effects on BP that are different from the Gper1 +/+ rat to Gper1 +/+ rat transfer. However, based on previous studies, 20 wherein we did not observe any strain-dependent effects on BP, such differences, albeit unlikely, remain to be tested. Therefore, it could be possible that the BP effects we are seeing in the Gper1 −/− rats in this experiment are because of the experiment itself and not the microbiotal transfer.
In vivo, circulating SCFAs are among the best characterized end products of gut microbial fermentation, which have been linked to the regulation of BP in the host. [35] [36] [37] Among these, acetate, propionate, and butyrate are microbiota-derived SCFAs produced in the cecum and large intestine from where they are transported into portal circulation where they exert a vasorelaxant effect. 38, 39 Our data show that mesenteric arteries from Gper1 −/− rats reveal a previously unrecognized function of Gper1 as a modulator of the biological actions of SCFAs. Additional studies are needed to determine whether this results from a direct effect of SCFAs on Gper1 or subsequent signaling crosstalk between Gper1 and SCFAs receptors of the GPR family. Although a response of Gper1 to SCFAs was identified in this study, the vasodilatory response was small compared with what would be expected with the large BP changes noted. Therefore, although these results show a possible link between Gper1, gut microbiota, and BP control, the exact mechanism by which deletion of Gper1 improves BP is still unknown. In addition, the direct mechanism by which the deletion of Gper1 significantly alters the microbiome needs further investigation. Although there are reports in the literature of GPRs interacting with microbiota, 40, 41, 43 the relationship between them is complex and difficult to study. Perhaps, one of the complications of studying this GPR-microbiotal relationship is that there are multiple GPRs that have both similar and opposing effects. All of these receptors together exert physiological effects. Therefore, trying to determine the interactions between just one of them and the microbiota is expected to be difficult. Considering this difficulty, our finding that deletion of Gper1 caused alterations in microbiotal composition is significant and suggests that the other GPRs were perhaps unable to compensate for the effects of the deletion of Gper1. This makes Gper1 an interesting target for microbiotal-dependent cardiovascular effects.
Gper1 maps on to chromosome 7p22, a region implicated in hypertension in humans, 7, 44 and a recent survey in normal healthy adults has shown that impaired Gper1 function might be associated with increased BP and risk of hypertension. 45 Interestingly, a common genetic variant of GPER1, Gper1P16L, was found to be hypofunctional and associated with increased BP in females. 45 It will be interesting to study, whether, like in the rat models, microbiotal compositions are linked to the host allelic variants of human GPER1. In addition, contemplation of Gper1 as a target for therapeutic intervention in the management of cardiovascular disease may require caution because of the contextual dependency of the function of Gper1 on the host genome and the associated microbiome.
Perspectives
In this study, we sought to study the BP regulatory role of Gper1 in the Dahl salt-sensitive rat model of hypertension. Compared with their wild-type littermates, Gper1 −/− rats showed significantly lower BP effect, which was abolished when the gut microbiota of the Gper1 −/− rats was swapped with that of wild-type rats. In addition, using ex vivo model, we demonstrated impaired vasorelaxation in Gper1 − rats mesenteric arteries in response to SCFAs, which are major metabolites of gut microbiota. These data provide important evidence to suggest a role of microbiota in the BP regulation by Gper1. Given the growing evidence for host-microbiotal interactions in health and disease, our data support Gper1 as one of the host genomic factors responsible for crosstalk with microbiota to regulate cardiovascular physiology and prompts investigation into further precise mechanisms.
